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• Up to 84% of term neonates develop jaundice, an early sign of 
hyperbilirubinemia that warrants evaluation by bilirubin measurement 
(Muchowski, 2014)
• AAP recommends that every infant receive a systematic evaluation of 
hyperbilirubinemia risk prior to hospital discharge
• Serum bilirubin testing involves a needle stick, which carries numerous 
adverse effects including anxiety, pain, altered nociceptive pathways and cost 
for the family (Lago et al., 2017; AAP Subcommittee on Hyperbilirubinemia, 
2004)
• Transcutaneous bilirubin screening (TcB) can measure bilirubin without a 
needle stick 
• TcB has been shown to increase the rate of bilirubin screening while decreasing 
needle sticks
• TcB may offer reduced costs to families
• TcB is slightly less accurate than needle stick bilirubin at higher concentrations
• TcB may lead to increased phototherapy rates (Kuzniewicz, et al, 2009)
Methods
• Retrospective data analysis of two three-month phases
• Phase one: Prior to introduction of TcB 
• Phase two: Following the introduction of TcB
• Compared data for phase one and phase two regarding the following 
outcomes:
• Screening rates
• Needle stick rates
• Phototherapy treatment rates
• Cost per test
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• TcB increased the percent of infants screened for hyperbilirubinemia from 
21% to 83%. This was a statistically significant difference
• TcB introduction reduced percent of infants receiving needle testing for 
bilirubin screening from 21% to 20.6%. Though this was not found to be 
statistically significant, it was clinically significant, as 9 infants were spared 
needle sticks due to TcB screening
• Phototherapy use increased from 3.1% to 3.9% in the post-intervention 
period, but this was not a statistically significant difference.
• TcB results in a $27.30 charge to families, while needle stick testing results in 
a $60.30 charge
Evidence supports establishing a TcB threshold prior to needle stick testing 
follow up. The AAP states that TcB values of 15mg/dL do not necessitate 
needle stick follow up, but this is not a universally adopted standard. 
Therefore, establishment of a TcB threshold for needle stick testing could 
further reduce needle sticks and is an important area for further study. This 
quality improvement assessment highlights the need for formal study to 
establish an appropriate TcB threshold for needle stick follow up, and the 
effect of such a threshold on needle sticks.
The introduction of TcB increased bilirubin screening by 62%, which 
represents a statistically significant increase in systematic, evidence-based 
risk assessment for hyperbilirubinemia. Thus, TcB screening increases 
adherence to AAP recommendations for hyperbilirubinemia screening. 
While screening increased, needle stick rates decreased, which is a positive 
quality of care change for families.
Additionally, there is a cost benefit to families for using TcB instead of 
needle stick testing. However, it is important to have a consistent procedure 
for TcB use.
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Purpose:
• Determine the effect of transcutaneous bilirubin measurement on needle 
sticks
• Determine the effect of transcutaneous bilirubin measurement on 
phototherapy treatment 
• Determine the comparative cost-per-test of transcutaneous bilirubin 
measurement and needle stick bilirubin testing
